Hypervolemic treatment in acute non-arteriitic aion

Hypervolemic treatment in acute non-arteriitic aion - HAA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00012603

Enrollment

Registered

2017-07-18

Start date

2004-02-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H47.0

Interventions

Group 1: 250 cc 10% hydroxyethyl starch (molecular weight 200.000), i.v., once. CDI - measurements prior and 15min after infusion of HES

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Acute non-arteriitic AION

Exclusion criteria

Exclusion criteria: arteriitic AION

Design outcomes

Primary

Measure	Time frame
Perfusionparameters (Peak-systolic (PSV) and end-diastolic velocities (EDV) and Pourcelot´s resistive index (RI) are measured in the ophthalmic artery (OA), central retinal artery (CRA) and the short posterior ciliary arteries (PCA)) measured via Colour Doppler Imaging (CDI) prior and after infusion of HES. An increased blood flow is expected after infusion of HES.	—

Countries

Germany

Contacts

Public ContactNiklas Plange

Uniklinik RWTH Aachen, Augenklinik

nplange@ukaachen.de0241-80-88192

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 25, 2026